Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
EMSP Spring Conference 2015:
Top 10 highlights
EMSP’s 2015 Annual Conference enjoyed an audience of 150 stakeholders representing some of our key members and partners. As a…
EMSP Spring Conference 2015:
Top 10 highlights
EMSP’s 2015 Annual Conference enjoyed an audience of 150 stakeholders representing some of our key members and partners. As a…
EMSP 2015 Annual Conference: Presentations available
EMSP’s Annual Conference in Warsaw, Poland hosted, on 15 and 16 May, nearly 150 stakeholders interested in finding the best…
EMSP represented at DIA Europe meeting
EMSP’s Director of External Affairs Christoph Thalheim represented our organisation at the Drug Information Association’s (DIA) meeting of European health stakeholders,…
Clinical Drug Trials in Pediatric MS: Issues, Challenges and Hopes
by Jon Temme, MSIF Coordinating Consultant to the International Pediatric MS Study Group Many new medications to treat multiple sclerosis (MS) are…
Clinical Drug Trials in Pediatric MS: Issues, Challenges and Hopes
by Jon Temme, MSIF Coordinating Consultant to the International Pediatric MS Study Group Many new medications to treat multiple sclerosis (MS) are…
